Earlier this week, Life Biosciences, a biotech company focused on reversing age-related diseases, announced that it had dosed its first volunteer. A person with glaucoma has had an experimental treatment injected straight into their eyeball. The idea is to try to treat the disease—which can cause vision loss—by regenerating healthy nerves in the eye. But…
Executives who underestimate the risks of autonomous systems are leaving their organizations exposed to the fastest-growing attack vector in the enterprise.
AI phishing works because it exploits the way people communicate at work. Fixing it requires security teams and communications leaders working together.
SAP plans to buy German AI startup Prior Labs and invest heavily in it. It is also prohibiting customers’ agents use to a select few like Nvidia’s NemoClaw.
With Apple’s latest operating system updates, users will reportedly have their pick of which third-party AI models they want to use for a host of tasks.